Registered entities
Proteon Therapeutics, Inc.
Reg. No. 204580525United States
Innovation
9 patent families (6 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace dormant. Cited 1,007 times.
| Year | Filings |
|---|---|
| 2012 | 3 |
| 2013 | 4 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 1 |
Investor mix
17 investors on record; lead investors include Abingworth.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 11 | 65% |
| Bank & private debt | 1 | 6% |
| Other / undisclosed | 5 | 29% |